GSK (GLAXF)
GSK Statistics
Share Statistics
GSK has 4.05B shares outstanding. The number of shares has increased by -0.25% in one year.
| Shares Outstanding | 4.05B |
| Shares Change (YoY) | -0.25% |
| Shares Change (QoQ) | -0.31% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 3.71B |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 21.31 and the forward PE ratio is null. GSK's PEG ratio is -0.45.
| PE Ratio | 21.31 |
| Forward PE | n/a |
| PS Ratio | 1.75 |
| Forward PS | n/a |
| PB Ratio | 4.01 |
| P/FCF Ratio | 15.36 |
| PEG Ratio | -0.45 |
Enterprise Valuation
GSK has an Enterprise Value (EV) of 68.16B.
| EV / Sales | 2.17 |
| EV / EBITDA | 10.22 |
| EV / EBIT | 10.4 |
| EV / FCF | 19.08 |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 1.24.
| Current Ratio | 0.78 |
| Quick Ratio | 0.52 |
| Debt / Equity | 1.24 |
| Debt / EBITDA | 2.55 |
| Debt / FCF | 4.76 |
| Interest Coverage | 6.28 |
Financial Efficiency
Return on Equity is 18.84% and Return on Invested Capital is 8.51%.
| Return on Equity | 18.84% |
| Return on Assets | 4.33% |
| Return on Invested Capital | 8.51% |
| Revenue Per Employee | $457.18K |
| Profits Per Employee | $37.52K |
| Employee Count | 68,629 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 1.6 |
Taxes
| Income Tax | 526M |
| Effective Tax Rate | 15.13% |
Stock Price Statistics
The stock price has increased by -3.84% in the last 52 weeks. The beta is 0.3, so GSK's price volatility has been higher than the market average.
| Beta | 0.3 |
| 52-Week Price Change | -3.84% |
| 50-Day Moving Average | 18.56 |
| 200-Day Moving Average | 18.72 |
| Relative Strength Index (RSI) | 55.61 |
| Average Volume (20 Days) | 2.58K |
Income Statement
In the last 12 months, GSK had revenue of 31.38B and earned 2.58B in profits. Earnings per share was 0.63.
| Revenue | 31.38B |
| Gross Profit | 22.33B |
| Operating Income | 4.02B |
| Net Income | 2.58B |
| EBITDA | 6.67B |
| EBIT | 4.12B |
| Earnings Per Share (EPS) | 0.63 |
Balance Sheet
The company has 3.69B in cash and 16.99B in debt, giving a net cash position of -13.29B.
| Cash & Cash Equivalents | 3.69B |
| Total Debt | 16.99B |
| Net Cash | -13.29B |
| Retained Earnings | 7.8B |
| Total Assets | - |
| Working Capital | - |
Cash Flow
In the last 12 months, operating cash flow was 6.55B and capital expenditures -2.98B, giving a free cash flow of 3.57B.
| Operating Cash Flow | 6.55B |
| Capital Expenditures | -2.98B |
| Free Cash Flow | 3.57B |
| FCF Per Share | 0.88 |
Margins
Gross margin is 71.16%, with operating and profit margins of 12.82% and 8.21%.
| Gross Margin | 71.16% |
| Operating Margin | 12.82% |
| Pretax Margin | 11.08% |
| Profit Margin | 8.21% |
| EBITDA Margin | 21.25% |
| EBIT Margin | 12.82% |
| FCF Margin | 11.38% |
Dividends & Yields
GLAXF pays an annual dividend of $0.98, which amounts to a dividend yield of 4.39%.
| Dividend Per Share | $0.98 |
| Dividend Yield | 4.39% |
| Dividend Growth (YoY) | 0.33% |
| Payout Ratio | 119.23% |
| Earnings Yield | 4.69% |
| FCF Yield | 6.51% |
Analyst Forecast
Currently there are no analyst rating for GLAXF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jul 19, 2022. It was a backward split with a ratio of 4:5.
| Last Split Date | Jul 19, 2022 |
| Split Type | backward |
| Split Ratio | 4:5 |
Scores
| Altman Z-Score | null |
| Piotroski F-Score | null |